肠道葡萄糖吸收和早期食后葡萄糖反应之间的因果关系的遗传证据:孟德尔的随机化研究
Simon Peschard1,2, Violeta Raverdy1,3,4, Pierre Bauvin1,3
1European Genomic Institute for Diabetes, University Lille, Lille, France.
Diabetes
|March 18, 2024
概括
减少肠道-葡萄糖共运输体1 (SGLT1) 的表达因果性地降低了早期的葡萄糖反应. 这一遗传发现可能有助于通过准葡萄糖吸收来控制2型糖尿病风险.
科学领域:
- 代谢障碍 代谢障碍 代谢障碍
- 遗传学 遗传学 是一个
- 糖尿病研究研究 糖尿病研究
背景情况:
- 餐后葡萄糖反应是2型糖尿病的关键风险因素.
- 肠道葡萄糖吸收受-葡萄糖配运输体1 (SGLT1) 的影响,影响早期的葡萄糖水平.
- 门德尔随机化 (MR) 可以调查因果关系.
研究的目的:
- 使用MR估计肠道SGLT1表达对早期食后葡萄糖反应的因果关系.
- 探索SGLT1对严重肥胖个体葡萄糖代谢的遗传影响.
主要方法:
- 孟德尔的随机化研究涉及1,547名患有II/III类肥胖症的个人.
- 使用了SGLT1基因定型,口服葡萄糖耐受性测试和骨活检.
- 采用功能丧失的SGLT1单元型作为一个仪器变量.
主要成果:
- 在12.8%的参与者中发现了功能丧失的SGLT1单元型,与SGLT1表达的减少和30分钟后负载血糖 (Δ30葡萄糖) 的降低有关.
- 观察分析显示,SGLT1表达的1-SD降低与 -0.097 mmol/L Δ30 葡萄糖降低相关.
- 核磁共振分析显示了显著的因果关系:SGLT1表达的减少导致葡萄糖降低 -0.353 mmol/L Δ30.
结论:
- 核磁共振分析提供了遗传证据,表明肠道SGLT1表达减少因果性地降低了早期后负载葡萄糖反应.
- 这些发现表明,通过通过SGLT1抑制向肠道葡萄糖吸收来针对2型糖尿病的潜在治疗策略.
相关概念视频
Glucose Absorption Into the Small Intestine
31.6K
Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and...
31.6K
Glucose Transporters
22.7K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.7K
Genome-wide Association Studies-GWAS
13.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.4K
Glucagon-like Receptor Agonists
321
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
321


